Amgen (NASDAQ:AMGN) Price Target Cut to $291.00
Amgen (NASDAQ:AMGN – Free Report) had its price target cut by Morgan Stanley from $300.00 to $291.00 in a research note released on Wednesday morning, Benzinga reports. They currently have an equal weight rating on the medical research company’s stock. Several other research firms also recently weighed in on AMGN. Argus upped their price objective […]
More Stories
Asana (NYSE:ASAN) Earns Sector Perform Rating from Analysts at Scotiabank
Equities research analysts at Scotiabank started coverage on shares of Asana (NYSE:ASAN – Get Free Report) in a research report...
Asana (NYSE:ASAN) Earns Sector Perform Rating from Analysts at Scotiabank
Equities research analysts at Scotiabank started coverage on shares of Asana (NYSE:ASAN – Get Free Report) in a research report...
EMX Royalty Co. (NYSEAMERICAN:EMX) Short Interest Down 12.1% in October
EMX Royalty Co. (NYSEAMERICAN:EMX – Get Free Report) was the recipient of a significant drop in short interest during the...
Asana (NYSE:ASAN) Earns Sector Perform Rating from Analysts at Scotiabank
Equities research analysts at Scotiabank started coverage on shares of Asana (NYSE:ASAN – Get Free Report) in a research report...
EMX Royalty Co. (NYSEAMERICAN:EMX) Short Interest Down 12.1% in October
EMX Royalty Co. (NYSEAMERICAN:EMX – Get Free Report) was the recipient of a significant drop in short interest during the...
EMX Royalty Co. (NYSEAMERICAN:EMX) Short Interest Down 12.1% in October
EMX Royalty Co. (NYSEAMERICAN:EMX – Get Free Report) was the recipient of a significant drop in short interest during the...